Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/71941
DC FieldValueLanguage
dc.contributor.authorFornell-Perez, Robertoen_US
dc.contributor.authorVivas-Escalona, Valentinaen_US
dc.contributor.authorAranda-Sanchez, Joelen_US
dc.contributor.authorGonzalez-Dominguez, M. Carmenen_US
dc.contributor.authorRubio-Garcia, Janoen_US
dc.contributor.authorAlemán-Flores, Patriciaen_US
dc.contributor.authorLozano-Rodriguez, Alvaroen_US
dc.contributor.authorPorcel-de-Peralta, Gabrielaen_US
dc.contributor.authorLoro Ferrer, Juan Franciscoen_US
dc.date.accessioned2020-05-04T10:56:07Z-
dc.date.available2020-05-04T10:56:07Z-
dc.date.issued2020en_US
dc.identifier.issn0033-8362en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/71941-
dc.description.abstractObjective: To assess the added value of diffusion-weighted imaging (DWI) to high-resolution T2-weighted sequences (HRT2w) in MRI detection of extramural venous infiltration (EMVI), according to the previous experience of radiologists. Methods: A cross-sectional study of a retrospective database including 1.5 T MRI records from 100 patients with biopsy-proven rectal cancer (2011-2016; 75 male/25 female, average 63 y/o), which included primary staging (54) and post-chemoradiotherapy follow-up MRIs (46). The reference standard was histology of surgical specimens. All cases were individually blindly reviewed by ten radiologists: three specialists in abdominal radiology, three specialized in different areas and four residents. In each case, the presence of EMVI was assessed twice: first, using just HRT2w; second, with DWI added to HRT2w. The results were pooled by experience, analyzing sensitivity, specificity, accuracy (area under ROC curve), likelihood ratios, predictive values and overstaging/understaging. Results Addition of DWI improved diagnostic performance by specialists radiologists, particularly post-chemoradiotherapy (accuracy 0.74-0.84; positive likelihood ratio 3.9-9.1; overstaging 16-8%), less so at primary staging (specificity 76-87.2%; overstaging 21-11%). Non-specialist radiologists also improved, but only at primary staging (accuracy 0.59-0.63). Residents showed small changes, except for notably increased sensitivity in both primary staging (35.7-43%) and post-chemoradiotherapy (41.7-58.3%) staging, at the expense of increased overstaging. Conclusions: The addition of DWI improved the diagnostic performance of EMVI by experienced radiologists, downgrading overstaging, especially in post-chemoradiotherapy follow-up. It resulted in fewer changes for inexperienced radiologists (enhanced primary staging) and residents (increased sensitivity).en_US
dc.languageengen_US
dc.relation.ispartofRadiologia Medicaen_US
dc.sourceRadiologia Medica [ISSN 0033-8362], v. 125, p. 522–530en_US
dc.subject320101 Oncologíaen_US
dc.subject320111 Radiologíaen_US
dc.subject.otherVascular Invasionen_US
dc.subject.otherPrognostic-Significanceen_US
dc.subject.otherChemotherapyen_US
dc.subject.otherMetastasisen_US
dc.subject.otherDiseaseen_US
dc.subject.otherMagnetic Resonance Imagingen_US
dc.subject.otherRectal Neoplasmsen_US
dc.subject.otherDiffusion-Weighted Imagingen_US
dc.subject.otherBlood Vesselsen_US
dc.titlePrimary and post-chemoradiotherapy MRI detection of extramural venous invasion in rectal cancer: the role of diffusion-weighted imagingen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s11547-020-01137-7en_US
dc.identifier.isi000511074000004-
dc.identifier.eissn1826-6983-
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid34800023-
dc.contributor.daisngid31991154-
dc.contributor.daisngid31991734-
dc.contributor.daisngid34804087-
dc.contributor.daisngid11250725-
dc.contributor.daisngid6193922-
dc.contributor.daisngid6665551-
dc.contributor.daisngid32004636-
dc.contributor.daisngid29163246-
dc.description.numberofpages9en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Fornell-Perez, R-
dc.contributor.wosstandardWOS:Vivas-Escalona, V-
dc.contributor.wosstandardWOS:Aranda-Sanchez, J-
dc.contributor.wosstandardWOS:Gonzalez-Dominguez, MC-
dc.contributor.wosstandardWOS:Rubio-Garcia, J-
dc.contributor.wosstandardWOS:Aleman-Flores, P-
dc.contributor.wosstandardWOS:Lozano-Rodriguez, A-
dc.contributor.wosstandardWOS:Porcel-de-Peralta, G-
dc.contributor.wosstandardWOS:Loro-Ferrer, JF-
dc.date.coverdate2020en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,581
dc.description.jcr3,469
dc.description.sjrqQ2
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0002-0517-8209-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameLoro Ferrer, Juan Francisco-
Appears in Collections:Artículos
Show simple item record

WEB OF SCIENCETM
Citations

48
checked on Jul 21, 2024

Page view(s)

97
checked on Jan 27, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.